Rotenone is the main organophosphate component involved in increased PD risk through promotion of mitochondrial dysfunction by inhibiting mitochondrial complex I and ROS-activated aggregation of α-synuclein (Betarbet et al., 2000). This evidence concerns the gene SNCA and Parkinson disease.